Method
Fifty patients with a diagnosis of End Stage Renal Disease (irrespective of the underlying cause), and those who were on hemodialytic support for more than 3 months were studied over a period of one year. Peripheral arterial disease was diagnosed on the basis of the ankle -brachial index, which was the ratio of the resting systolic blood pressure in the arteries of the ankle to that of the brachial artery, measured by using a standard mercury manometer with a cuff of appropriate size and the Doppler ultrasound. Patients with ankle -brachial index ≤0.9 were considered positive for peripheral arterial disease.
Result
A total of 50 End Stage Renal Disease patients were analyzed. The mean age of the patient was 49.81±12.63 years. The age range was from 18-79 years. Majority of them were males 64% (n=32). Peripheral arterial disease defined by ankle -brachial index ≤0.9 was present in 30% (n=15) of patients. The three major cause of End Stage Renal Disease in the study population was Chronic Glomerulonephritis 40 % (n=20), Type 2 Diabetes Mellitus 28 % (n=14) and Hypertension 24 % (n=12). Type 2 Diabetes Mellitus was the commonest cause 53% (n=8) of End Stage Renal Disease in patients with peripheral arterial disease followed by hypertension 33% (n=5). On univariate analysis, peripheral arterial disease was found to be significantly associated with age >40 years (p value= 0.003; OR=14.8; CI=1.75-125.27), Type 2 Diabetes Mellitus (p value= 0.009; OR=5.4; CI=1.44-21.14), parasthesia of lower limbs (p value= 0.001; OR=10; CI-2.31-43.16), and intact PTH >300 ng/ml (p value =0.006; OR=5.7; CI=1.55-21.50). However on multivariate analysis only parasthesia of lower limbs and intact PTH >300 ng/ml were significantly and independently associated with peripheral arterial disease, while other variables were not significant.
Conclusion
Peripheral arterial disease was common occurrence in End Stage Renal Disease patients on hemodialysis. Ankle -brachial index needs to be included as a routine assessment in End Stage Renal Disease patients to detect peripheral arterial disease at its earliest. 2 Majority of ESRD patient in our center are also in hemodialysis.
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Peripheral Arterial Disease (PAD) is a common problem in Chronic Kidney Disease. Moreover, its prevalence is seen to be much higher among hemodialysis patients than in the general population with an estimated prevalence ranging from 17% and 48%. 3, 4 Knowledge of the PAD in patients with CKD (Chronic Kidney Disease) is limited because of a lack of routine evaluation and detection. The prevalence of PAD appears to be higher among ESRD (End Stage Renal Disease) patients than in the general population due to dialysis or uremia-associated risk factors. 3 It is also known that peripheral arterial disease (PAD) is a strong predictor of Coronary artery disease and this is of particular interest to Nephrologists because the risk for PAD is increased in CKD but it is unfortunate that PAD is often overlooked as a source of morbidity and as a cardiovascular risk factor in ESRD population. 5 Early detection of PAD identifies a group of patients who would benefit from aggressive cardiovascular risk factor modification and prevent the adverse outcomes like pain at rest, risk of tissue necrosis, and even amputation of legs. [6] [7] [8] Many studies have been conducted to know the prevalence of peripheral arterial disease in hemodialysis population. However no such study had been conducted so far in Nepal. This study was carried out with an objective to assess the prevalence of Peripheral Arterial Disease in End Stage Renal Disease (ESRD) Patients on Hemodialysis from central Nepal.
METHODS
This hospital based cross sectional study was carried out at Hemodialysis Unit of College of Medical Sciences Teaching hospital over a period of one year; from October 2010 to September 2011, where 50 cases of hemodialysis patients were prospectively analyzed. Patients with a diagnosis of ESRD (End Stage Renal Disease), irrespective of the underlying cause and who were on maintenance Hemodialysis for more than 3 months were included in the study. ESRD was defined when there was irreversible loss of GFR of ≤5 ml/min on the basis of Cock-Croft and Gault Equation.
9,10 All the patients included in the study were explained about the nature of the study and a written consent was taken. The Institutional Review board has given the ethical clearance for the study.
Patient with documented diagnosis of peripheral arterial calcification, patient with bilateral arteriovenous fistula and patient with non-compressible upper and or lower limb vessels were excluded from the study. Non Compressible vessel was defined as an ankle-brachial index (ABI) > 1.30 or an apparent lower extremity systolic pressure above 300 mmHg. 11 An ultrasound Doppler (TOSHIBIA XARIO, SSA-660A) machine with 7.5 MHZ transducer was used to look for and document the Peripheral arterial disease and to rule out the possibility of Medial arterial calcification. The highest systolic blood pressure in Posterior tibial artery or dorsalis pedis artery (whichever was high) was taken and then divided by the systolic blood pressure in the brachial artery from the upper limb to calculate the ABI. Patients with ABI ≤0.9 was considered positive for peripheral arterial disease. 7 Tests of inter observer and intra observer variability revealed excellent reproducibility in the readings. ESRD (End stage renal disease) was defined by e-GFR ≤ 5 ml/min, which was calculated by using Cock Croft and Gault equation.
9,10 Intact PTH was estimated by mid-region radioimmunoassay technique in the random blood sample. Data was carefully entered on MS XP sheet and then the data was converted to SPSS PC+ 16 version for statistical analysis. Chi square (X 2 ) test was used to examine the association between ABI groups (ABI ≤0.9 and ABI>0.9). Ratio, mean and standard deviation were calculated for descriptive data.
RESULTS
The mean age of the patient enrolled in the study was 49.81 years ± 12.63 years and the mean age of the patient who had PAD was 58.27 years ± 13.11 years. The majority of the cases in our hemodialysis population were > 40 years, accounting up to 62% (n=31). Similarly in the PAD group, (n=14) were of age > 40 years and only (n=1) was of age ≤40 years. Majority of the Patients in the study were males 64% (n=32) and 36 % (n=18) females. Out of patients who had PAD, (n=10) majority were males approximately (n=10) and (n=5) were females. Peripheral arterial disease was present in 30% (n=15) of patients. Symptomatic PAD (ABI ≤0.9) was present in (n=12) patients and asymptomatic PAD present in (n=3) patients. However none of the patient had classical symptom of PAD in the form of intermittent leg claudication and or the rest pain. The three major causes of ESRD in the study population on hemodialysis were Chronic Glomerulonephritis 40 % (n=20) followed by Type 2 DM (n=14) and then Hypertension (n=12). Out of 20 cases with CGN, (n=2) had PAD. Similarly, out of 14 cases with Type 2 DM, (n=8) had PAD and out of 12 hypertensive patients (n=5) had PAD. Out of 49 Hypertensive patients, (n=15) of patients had PAD. Similarly, out of 14 Type 2 DM, (n=8) had PAD and out of 14 CCF patients (n=5) had PAD. On statistical analysis, Type 2 DM was significantly associated with PAD. Twelve cases (n=12) in PAD group were symptomatic and the predominant symptom was parasthesia of lower limbs. None of the patients in the study group had classical history suggestive of PAD, in the 
DISCUSSION
Our study is the first of its kind in Nepal, to evaluate the prevalence of Peripheral Arterial Disease in hemodialysis patients using ABI. Different studies had come with different prevalence of PAD in hemodialysis population. [12] [13] [14] The difference in prevalence between different series could be because of difference in study methodology and design.
Our study showed a 30% prevalence of PAD, which is a higher prevalence of PAD in hemodialysis patients. This is in accordance with the data published in series like DOPPS. 15 PAD is usually seen in older people in general populations. 16 However, in hemodialysis patients; even younger patients can have a high prevalence of PAD because of uremia and dialysis associated factors. But our study showed the prevalence of PAD being higher in older people. The reason for not finding younger patients with PAD in our study may be because of the fact that majority of our patients, 62 % (n= 31) were of advanced age i.e. age > 40 years and majority of them were in hemodialysis for less than one year duration. The prevailing notion is that peripheral arterial disease is common in males in general population. [17] [18] [19] This notion was maintained even in our study. However the frequent association of male gender with PAD in ESRD population is still unknown.
In terms of symptomatology, twelve (n=12) of PAD patients were clinically symptomatic in our study which was similar to a study done by Ogata et al in which 240 (76.4%) of 315 hemodialysis patients were symptomatic. 20 Majority of patients, 56 % (n=28) in our study were asymptomatic. These data suggest that clinicians who utilize a classic history of claudication alone to detect PAD were more likely to miss the diagnosis. To strengthen this fact in some studies it was shown that 85% to 90% of the PAD diagnoses were missed when classic history of claudication alone was utilized to detect PAD. [17] [18] [19] Hence the diagnosis of PAD may be missed unless if not looked for by using some tools.
In PAD cohort of our study, the major comorbidity was HTN which was present in all the patients followed by Type 2 DM present in (n=8) of cases. The prevalence of PAD in patients with CKD (Chronic Kidney Disease) and Type 2 DM is two to four fold greater than that of normal population. 21, 22 Therefore, it may be logical to propose that CKD/ESRD also further predisposes patients with diabetes to the development of PAD. There was a significant association of Type 2 Diabetes Mellitus with PAD in our study (p value = 0.009). Although hypertension is a risk factor for PAD among patients without ESRD. 23 An association of hypertension with PAD among hemodialysis patients has not been reported yet. Similar negative association of PAD with hypertension was also shown in other studies. [24] [25] [26] [27] [28] No significant association was observed between HTN and PAD in our study as well.
In PVD group of our study, 67.7% (n=10) cases had elevated intact PTH level with a cut off value of > 300 ng/ml. On analysis, this finding was of important significance. It was found that there was a significant association between elevated intact PTH level and PVD. On multiple logistic regression analysis also intact PTH value>300 ng/ml was significantly and independently associated with PVD. This significant association between elevated intact PTH and PVD is a unique finding in our study. Previous studies like DOPPS had failed to show the significant association of intact PTH and PVD. 15 This contradictory finding in our study needs further analysis with a larger sample size and randomized controlled trials.
CONCLUSION
The present study demonstrated the high prevalence of Peripheral Arterial Disease in CKD patients on hemodialysis. Type 2 DM Mellitus was the commonest cause of End Stage Renal Disease in patients with Peripheral Arterial Disease. The significant association between elevated intact PTH and Peripheral Arterial Disease is a unique finding in our study. Previous studies had failed to show the significant association of intact PTH and Peripheral Arterial Disease.
This unique finding in our study warrants further analysis with a larger sample size.
